RecruitingNCT03949972

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)


Sponsor

Prof. Dr. Paul Brinkkoetter

Enrollment

500 participants

Start Date

Apr 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

In a monocentric, later multicentric prospective approach the FOrMe registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) aims to generate a longitudinal cohort of 150 pediatric cases of idiopathic nephrotic syndrome and 350 adult cases of biopsy-proven Minimal Change Disease (MCD) or Focal and Segmental Glomerular Sclerosis (FSGS) over 10 years. The registry will provide a repository for biomaterials such as blood samples, DNA, urine, feces, and tissue biopsies that will be accessible to collaborators to facilitate future research on pathogenesis, diagnostics, and treatment.


Eligibility

Plain Language Summary

Simplified for easier understanding

The FOrMe Registry is a German national registry for patients with focal segmental glomerulosclerosis (FSGS) — a kidney disease where scar tissue forms in the kidney's filtering units (glomeruli), causing protein loss in urine and progressive kidney failure. FSGS is a rare and serious condition, and because patient numbers at any one center are small, a national registry is essential to gather enough data to understand the disease and develop better treatments. By enrolling patients across Germany, the registry will track disease course, treatment responses, complications, and long-term outcomes. Patients contribute data to a shared resource that benefits everyone with this condition. You may be eligible if: - You have been diagnosed with focal segmental glomerulosclerosis (FSGS) - You are being treated at a participating German medical center - You consent to contribute your medical data to the registry You may NOT be eligible if: - You have another form of kidney disease (not FSGS) - You are unable to provide informed consent - You do not receive care at a participating center Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiosampling

Biosampling at initial visit and follow-up visits


Locations(12)

University Hospital of Cologne

Cologne, North Rhine-Westphalia, Germany

Uniklinik RWTH Aachen

Aachen, Germany

Charité University Hospital

Berlin, Germany

Kindernierenzentrum Bonn

Bonn, Germany

Kindernephrologie Dachau

Dachau, Germany

University Hospital Erlangen

Erlangen, Germany

University Hospital Essen

Essen, Germany

University Hospital Heidelberg

Heidelberg, Germany

Klinikum St. Georg

Leipzig, Germany

University Hospital Marburg

Marburg, Germany

University Hospital Münster

Münster, Germany

Klinikum Stuttgart

Stuttgart, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03949972


Related Trials